The Minnesota Cancer Clinical Trials Network (MNCCTN) aims to improve cancer outcomes for all Minnesotans through greater access to cancer clinical trials in prevention and treatment.
The impact of cancer in Minnesota
Nearly half of all Minnesotans will be diagnosed with a potentially life-threatening cancer during their lifetimes
One out of four Minnesotans die of cancer
To impact these grim statistics, healthcare providers across the state need access to cutting-edge cancer research, including cancer clinical trials.
September is Leukemia & Lymphoma Awareness Month. These common cancers are both types of blood cancer. Leukemia affects the blood and bone marrow, while lymphoma affects the lymph nodes.